dc.contributor.author
Langmia, Immaculate M.
dc.contributor.author
Kräker, Kristin
dc.contributor.author
Weiss, Sara E.
dc.contributor.author
Haase, Nadine
dc.contributor.author
Schütte, Till
dc.contributor.author
Herse, Florian
dc.contributor.author
Dechend, Ralf
dc.date.accessioned
2019-06-06T14:01:52Z
dc.date.available
2019-06-06T14:01:52Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/24702
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-2462
dc.description.abstract
Intrauterine growth restriction (IUGR) is a condition whereby a fetus is unable to achieve its genetically determined potential size. IUGR is a global health challenge due to high mortality and morbidity amongst affected neonates. It is a multifactorial condition caused by maternal, fetal, placental, and genetic confounders. Babies born of diabetic pregnancies are usually large for gestational age but under certain conditions whereby prolonged uncontrolled hyperglycemia leads to placental dysfunction, the outcome of the pregnancy is an intrauterine growth restricted fetus with clinical features of malnutrition. Placental dysfunction leads to undernutrition and hypoxia, which triggers gene modification in the developing fetus due to fetal adaptation to adverse utero environmental conditions. Thus, in utero genemodification results in future cardiovascular programming in postnatal and adult life. Ongoing research aims to broaden our understanding of the molecular mechanisms and pathological pathways involved in fetal programming due to IUGR. There is a need for the development of effective preventive and therapeutic strategies for the management of growth-restricted infants. Information on the mechanisms involved with in utero epigenetic modification leading to development of cardiovascular disease in adult life will increase our understanding and allow the identification of susceptible individuals as well as the design of targeted prevention strategies. This article aims to systematically review the latest molecular mechanisms involved in the pathogenesis of IUGR in cardiovascular programming. Animal models of IUGR that used nutrient restriction and hypoxia to mimic the clinical conditions in humans of reduced flow of nutrients and oxygen to the fetus will be discussed in terms of cardiac remodeling and epigenetic programming of cardiovascular disease. Experimental evidence of long-term fetal programming due to IUGR will also be included.
en
dc.rights.uri
https://creativecommons.org/licenses/by/4.0/
dc.subject
placental dysfunction
en
dc.subject
gene modification
en
dc.subject
intra uterine growth restriction
en
dc.subject
cardiovascular programming
en
dc.subject.ddc
600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::610 Medizin und Gesundheit
dc.title
Cardiovascular Programming During and After Diabetic Pregnancy: Role of Placental Dysfunction and IUGR
dc.type
Wissenschaftlicher Artikel
dcterms.bibliographicCitation.articlenumber
215
dcterms.bibliographicCitation.doi
10.3389/fendo.2019.00215
dcterms.bibliographicCitation.journaltitle
Frontiers in Endocrinology
dcterms.bibliographicCitation.originalpublishername
Frontiers Media S.A.
dcterms.bibliographicCitation.volume
10
refubium.affiliation
Charité - Universitätsmedizin Berlin
refubium.resourceType.isindependentpub
no
dcterms.accessRights.openaire
open access
dcterms.bibliographicCitation.pmid
31024453
dcterms.isPartOf.issn
1664-2392